Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.
Sylke HaalMaimoena S S GumanL Maurits de BrauwRuben SchoutenRuben N van VeenPaul FockensVictor E A GerdesRogier P VoermansMarcel G W DijkgraafPublished in: The British journal of surgery (2022)
UDCA prophylaxis after RYGB in patients without gallstones before surgery was cost-effective.